Damora Therapeutics, Inc. (DMRA)
24.88
+0.04
(+0.16%)
USD |
NASDAQ |
May 29, 16:00
24.88
0.00 (0.00%)
After-Hours: 20:00
Damora Therapeutics Shareholders Equity (Quarterly) : 510.26M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 670.81M |
| Incyte Corp. | 5.623B |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 535.44M |
| Total Liabilities (Quarterly) | 25.18M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 22.48 |
| Net Debt Paydown Yield | -0.02% |